Skip to content

The Brabant Study: a prospective cohort study among pregnant women

The Brabant Study: a prospective cohort study among pregnant women - The Brabant Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON52874
Enrollment
4000
Registered
2018-02-01
Start date
2018-05-13
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid dysfunction during pregnancy

Interventions

None listed

Sponsors

Universiteit van Tilburg
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Pregnant women (18+ y) who have their first antenatal visit

Exclusion criteria

Exclusion criteria: - Multiple pregnancy - Known endocrine disorder before pregnancy - Use of thyroid medication - Severe psychiatric disease (e.g. schizophrenia, borderline, bipolar disorder or depression with known suicidal ideation) - HIV - Drug or alcohol addiction problems - Any other disease resulting in treatment with drugs that are potentially adverse for the foetus and need careful follow-up during pregnancy (e.g. Type 2 Diabetes with use of insulin, Rheumatoid Arthritis with use of prednison or methotrexate, Multiple Sclerosis or Crohn's disease). - No access to internet

Design outcomes

Primary

MeasureTime frame
Thyroid hormone levels (TSH and fT4) and TPO-Ab and hCG assessed at 12, 20 and 28 weeks.

Secondary

MeasureTime frame
Pregnancy complications (e.g. pre-eclampsia, pre-term birth, SGA), mode of delivery (spontaneous versus instrumental delivery) and depressive symptoms related to thyroid trajectories and/or poor obstetric outcome.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)